Drug Trial Radar · NCT07722884
Tamsulosin Monotherapy Versus Combination Therapy With Tadalafil (2.5 mg vs 5 mg) in Managing Male LUTS Secondary to BPH
Last checked: Nov 20, 2026Latest source record: Jul 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
90
Planned (sponsor's estimate)
Start
Jul 1, 2026
Primary completion
Jan 1, 2027
Study completion Jan 1, 2027
Sponsor
- Lead sponsor
- Ain Shams UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jul 23, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 45 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study aims to evaluate the short-term impact and clinical outcomes of tamsulosin monotherapy versus combination therapy with tamsulosin plus tadalafil (2.5 mg vs. 5 mg) on lower urinary tract symptoms (LUTS) severity and patient quality of life in men with benign prostatic hyperplasia (BPH). It also seeks to determine whether the lower tadalafil dose provides adequate symptom relief while minimizing adverse effects over a 12-week follow-up period.
Conditions
- Safety
- Efficacy
- Tamsulosin
- Monotherapy
- Tadalafil
- Lower Urinary Tract Symptoms
- Benign Prostatic Hyperplasia
Interventions
Tamsulosin 0.4 mg + Tadalafil 2.5 mgDrug
Patients will receive Tamsulosin 0.4 mg once daily + Tadalafil 2.5 mg once daily
Tamsulosin 0.4 mg + Tadalafil 5 mgDrug
Patients will receive Tamsulosin 0.4 mg once daily + Tadalafil 5 mg once daily
Tamsulosin 0.4 mgDrug
Patients will receive Tamsulosin 0.4 mg once daily (monotherapy)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean change in International Prostate Symptom Score (IPSS) scoreTime frame: 12 weeks post-procedure
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Ain Shams University
Cairo, Cairo Governorate, Egypt · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.